Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report
- PMID: 9609500
- PMCID: PMC61304
- DOI: 10.1136/jamia.1998.0050305
Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report
Abstract
Background: Adverse drug events (ADEs) are both common and costly. Most hospitals identify ADEs using spontaneous reporting, but this approach lacks sensitivity; chart review identifies more events but is expensive. Computer-based approaches to ADE identification appear promising, but they have not been directly compared with chart review and they are not widely used.
Objectives: To develop a computer-based ADE monitor, and to compare the rate and type of ADEs found with the monitor with those discovered by chart review and by stimulated voluntary report.
Design: Prospective cohort study in one tertiary-care hospital.
Participants: All patients admitted to nine medical and surgical units in a tertiary-care hospital over an eight-month period.
Main outcome measure: Adverse drug events identified by the computer-based monitor, by chart review, and by stimulated voluntary report.
Methods: A computer-based monitoring program identified alerts, which were situations suggesting that an ADE might be present (e.g., an order for an antidote such as naloxone). A trained reviewer then examined patients' hospital records to determine whether an ADE had occurred. The results of the computer-based monitoring strategy were compared with two other ADE detection strategies: intensive chart review and stimulated voluntary report by nurses and pharmacists. The monitor and the chart review strategies were independent, and the reviewers were blinded.
Results: The computer monitoring strategy identified 2,620 alerts, of which 275 were determined to be ADEs. The chart review found 398 ADEs, whereas voluntary report detected 23. Of the 617 ADEs detected by at least one method, 76 ADEs were detected by both computer monitor and chart review. The computer monitor identified 45 percent; chart review, 65 percent; and voluntary report, 4 percent. The ADEs identified by computer monitor were more likely to be classified as "severe" than were those identified by chart review (51 versus 42 percent, p = .04). The positive predictive value of computer-generated alerts was 16 percent during the first eight weeks of the study; rule modifications increased this to 23 percent in the final eight weeks. The computer strategy required 11 person-hours per week to execute, whereas chart review required 55 person-hours per week and voluntary report strategy required 5.
Conclusions: The computer-based monitor identified fewer ADEs than did chart review but many more ADEs than did stimulated voluntary report. The overlap among the ADEs identified using different methods was small, suggesting that the incidence of ADEs may be higher than previously reported and that different detection methods capture different events. The computer-based monitoring system represents an efficient approach for measuring ADE frequency and gauging the effectiveness of ADE prevention programs.
Similar articles
-
Evaluation of a computer-based adverse-drug-event monitor.Am J Health Syst Pharm. 2008 Dec 1;65(23):2265-72. doi: 10.2146/ajhp080122. Am J Health Syst Pharm. 2008. PMID: 19020194
-
Identifying hospital admissions due to adverse drug events using a computer-based monitor.Pharmacoepidemiol Drug Saf. 2001 Mar-Apr;10(2):113-9. doi: 10.1002/pds.568. Pharmacoepidemiol Drug Saf. 2001. PMID: 11499849
-
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.JAMA. 1995 Jul 5;274(1):29-34. JAMA. 1995. PMID: 7791255
-
Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review.Am J Health Syst Pharm. 2007 Apr 15;64(8):842-9. doi: 10.2146/ajhp060335. Am J Health Syst Pharm. 2007. PMID: 17420201 Review.
-
Identifying drug safety issues: from research to practice.Int J Qual Health Care. 2000 Feb;12(1):69-76. doi: 10.1093/intqhc/12.1.69. Int J Qual Health Care. 2000. PMID: 10733086 Review.
Cited by
-
A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review.Drug Saf. 2024 Aug 19. doi: 10.1007/s40264-024-01470-0. Online ahead of print. Drug Saf. 2024. PMID: 39160354
-
Management of adverse events in a Moroccan regional hospital: a state of art and perspectives.Pan Afr Med J. 2024 Feb 19;47:69. doi: 10.11604/pamj.2024.47.69.41560. eCollection 2024. Pan Afr Med J. 2024. PMID: 38681100 Free PMC article.
-
Navigating Drug-Induced Adversities: A Python-Based Console Application for Causality Assessment Using the Naranjo Algorithm.Cureus. 2023 Dec 4;15(12):e49911. doi: 10.7759/cureus.49911. eCollection 2023 Dec. Cureus. 2023. PMID: 38174193 Free PMC article.
-
Deficiencies of Rule-Based Technology-Generated Antibiograms for Specialized Care Units.Antibiotics (Basel). 2023 Jun 3;12(6):1002. doi: 10.3390/antibiotics12061002. Antibiotics (Basel). 2023. PMID: 37370321 Free PMC article.
-
Evaluation of Detected Medication Errors Within the Operating Room at an Academic Medical Center.Hosp Pharm. 2023 Jun;58(3):309-314. doi: 10.1177/00185787221145110. Epub 2022 Dec 24. Hosp Pharm. 2023. PMID: 37216068 Free PMC article.
References
-
- Leape LL. Error in medicine. JAMA. 1995;272: 1851-7. - PubMed
-
- Bates DW, Cullen D, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274: 29-34. - PubMed
-
- Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997;227: 307-11. - PubMed
-
- Brennan TA, Leape LL, Laird N, et al. Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I. N Engl J Med. 1991;324: 370-6. - PubMed
-
- Leape LL, Brennan TA, Laird NM, et al. The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study II. N Engl J Med. 1991;324: 377-84. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
